Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

NephroCheck data compared to serum creatinine in various clinical settings.

Pajenda S, Ilhan-Mutlu A, Preusser M, Roka S, Druml W, Wagner L.

BMC Nephrol. 2015 Dec 9;16:206. doi: 10.1186/s12882-015-0203-5.

2.

DG-RAR for the treatment of symptomatic grade III and grade IV haemorrhoids: a 12-month multi-centre, prospective observational study.

Roka S, Gold D, Walega P, Lancee S, Zagriadsky E, Testa A, Kukreja AN, Salat A.

Eur Surg. 2013 Feb;45(1):26-30. Epub 2013 Feb 9.

3.

[Consensus statement haemorrhoidal disease].

Aigner F, Conrad F, Haunold I, Pfeifer J, Salat A, Wunderlich M; Konsensusgruppe der Arbeitsgemeinschaft für Coloproktologie (ACP) der Österreichischen Gesellschaft für Chirurgie, Fortelny R, Fritsch H, Glöckler M, Hauser H, Heuberger A, Karner-Hanusch J, Kopf C, Lechner P, Riss S, Roka S, Scheyer M.

Wien Klin Wochenschr. 2012 Mar;124(5-6):207-19. doi: 10.1007/s00508-011-0107-8. Epub 2012 Mar 2. German.

PMID:
22378598
4.

Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group.

Tausch C, Konstantiniuk P, Kugler F, Reitsamer R, Roka S, Pöstlberger S, Haid A; Austrian Sentinel Node Study Group.

Ann Surg Oncol. 2008 Dec;15(12):3378-83. doi: 10.1245/ASO.2006.08.010.

PMID:
19097267
5.

[Anal HPV infections].

Aigner F, Conrad F, Widschwendter A, Zangerle R, Zelger B, Haidenberger A, Roka S, Heim K, Höpfl R, Klimpfinger M, Rigler YM, Bonatti H, Pfeifer J, Maier A, Kirnbauer R, Salat A.

Wien Klin Wochenschr. 2008;120(19-20):631-41. doi: 10.1007/s00508-008-1059-5. German. No abstract available.

PMID:
19083168
6.

Neoadjuvant treatment of colorectal cancer with bevacizumab: the perioperative angiogenic balance is sensitive to systemic thrombospondin-1 levels.

Brostjan C, Gebhardt K, Gruenberger B, Steinrueck V, Zommer H, Freudenthaler H, Roka S, Gruenberger T.

Clin Cancer Res. 2008 Apr 1;14(7):2065-74. doi: 10.1158/1078-0432.CCR-07-4081.

7.

A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.

Konstantiniuk P, Schrenk P, Reitsamer R, Koeberle-Wuehrer R, Tausch C, Roka S, Riedl O, Poestlberger S, Hecke D, Janauer M, Haid A.

Breast. 2007 Oct;16(5):520-6. Epub 2007 Jun 12.

PMID:
17566737
8.

HMGA2 is associated with invasiveness but not a suitable marker for the detection of circulating tumor cells in breast cancer.

Fabjani G, Tong D, Wolf A, Roka S, Leodolter S, Hoecker P, Fischer MB, Jakesz R, Zeillinger R.

Oncol Rep. 2005 Sep;14(3):737-41.

PMID:
16077985
9.

Intraoperative frozen section examination of the sentinel lymph node in breast cancer.

Schrenk P, Konstantiniuk P, Wölfl S, Bogner S, Roka S, Pöstlberger S, Selim U, Urbania A, Gebhard B, Rudas M, Tausch Ch.

Rozhl Chir. 2005 May;84(5):217-22.

PMID:
16045116
10.

The impact of preoperative breast biopsy on the risk of sentinel lymph node metastases: analysis of 2502 cases from the Austrian Sentinel Node Biopsy Study Group.

Peters-Engl C, Konstantiniuk P, Tausch C, Haid A, Hoffmann B, Jagoutz-Herzlinger M, Kugler F, Redtenbacher S, Roka S, Schrenk P, Steinmassl D; Austrian Sentinel Node Biopsy Study Group.

Br J Cancer. 2004 Nov 15;91(10):1782-6.

11.

Prevalence of anal HPV infection in solid-organ transplant patients prior to immunosuppression.

Roka S, Rasoul-Rockenschaub S, Roka J, Kirnbauer R, Mühlbacher F, Salat A.

Transpl Int. 2004 Aug;17(7):366-9. Epub 2004 Jul 31.

12.

Primary hyperparathyroidism: is there a role for imaging? (Pro).

Roka R, Pramhas M, Roka S.

Eur J Nucl Med Mol Imaging. 2004 Sep;31(9):1322-4. Epub 2004 Jul 31. No abstract available.

PMID:
15338207
13.

Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer.

Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Roka S, Bachleitner T, Kandioler D, Steger G, Mittlböck M, Jakesz R.

Wien Klin Wochenschr. 2004 Jan 31;116(1-2):26-31.

PMID:
15030120
14.

High nuclear grade and negative estrogen receptor are significant risk factors for recurrence in DCIS.

Roka S, Rudas M, Taucher S, Dubsky P, Bachleitner-Hofmann T, Kandioler D, Gnant M, Jakesz R.

Eur J Surg Oncol. 2004 Apr;30(3):243-7.

PMID:
15028303
15.

Carcinoma showing thymic-like elements--a rare malignancy of the thyroid gland.

Roka S, Kornek G, Schüller J, Ortmann E, Feichtinger J, Armbruster C.

Br J Surg. 2004 Feb;91(2):142-5. Review.

PMID:
14760659
16.

Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.

Taucher S, Rudas M, Mader RM, Gnant M, Sporn E, Dubsky P, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger GG, Mittlböck M, Jakesz R.

Breast Cancer Res Treat. 2003 Dec;82(3):207-13.

PMID:
14703068
17.

Do we need HER-2/neu testing for all patients with primary breast carcinoma?

Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R.

Cancer. 2003 Dec 15;98(12):2547-53.

18.

The labelling of Nanocoll with [111In] for dual-isotope scanning.

Mitterhauser M, Wadsak W, Mien LK, Eidherr H, Roka S, Zettinig G, Angelberger P, Viernstein H, Kletter K, Dudczak R.

Appl Radiat Isot. 2003 Nov-Dec;59(5-6):337-42.

PMID:
14622932
19.

Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy.

Brostjan C, Bayer A, Zommer A, Gornikiewicz A, Roka S, Benkö T, Yaghubian R, Jakesz R, Steger G, Gnant M, Friedl J, Stift A.

Cancer. 2003 Nov 15;98(10):2291-301.

20.

Treatment and reconstruction after disconnection of the failed cervical esophagogastric anastomosis.

Roka S, Rath T, Jakesz R, Wenzl E.

Dis Esophagus. 2003;16(2):130-4.

PMID:
12823212

Supplemental Content

Loading ...
Support Center